THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME
Aim. To evaluate the prominence of fibrosis of the left atrium myocardium and to define the value of transforming growth factor beta 1 (TGF-beta1) and galectin-3 in development of myocardial fibrosis in atrial fibrillation (AF) patients with metabolic syndrome (MS).Material and methods. Totally, 58...
Saved in:
| Main Authors: | E. L. Zaslavskaya, A. N. Morozov, V. A. Ionin, I. Ma, S. Е. Nifontov, Е. I. Baranova, S. M. Yashin, E. V. Shlyakhto |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2018-03-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01) -
Role of galectin 3 and epicardial fat thickness in the development of atrial fibrillation in patients with metabolic syndrome
by: V. A. Ionin, et al.
Published: (2015-03-01) -
Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01) -
Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?
by: V. A. Ionin, et al.
Published: (2021-08-01) -
Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)